Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions

Lymphatic Malformation

Interventions

DRUG

Sirolimus (RAPAMUNE)

Use of different doses of the same drug

Trial Locations (1)

RECRUITING

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors

lead

West China Hospital

OTHER